Aclarion (ACON) said Monday Scripps Health will add its Nociscan technology platform to help find sources of chronic low back pain at Scripps facilities in San Diego area.
Shares surged 123% as intraday trading volume soared to more than 69 million shares from a daily average of about 646,000.
BioXcel Therapeutics (BTAI) said Monday that the US Food and Drug Administration has concluded that the inspection of a single site in its TRANQUILITY II Phase 3 trial is closed.
The company said the conclusion further supports reliability of data from the trial of BXCL501.
Shares more than doubled as trading volume catapulted to over 138 million from a daily average of about 1.91 million.
Allegro MicroSystems (ALGM) shares soared 17% after Bloomberg reported Sunday ON Semiconductor (ON) is working on a potential acquisition of Allegro.
Over 7.3 million shares traded intraday versus a daily average of roughly 2.45 million.
Price: 8.44, Change: +5.09, Percent Change: +151.88
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。